BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11493421)

  • 21. Breast MR imaging in the diagnostic setting.
    Schnall M; Orel S
    Magn Reson Imaging Clin N Am; 2006 Aug; 14(3):329-37, vi. PubMed ID: 17098174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
    Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
    Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fat suppression with spectrally selective inversion vs. high spectral and spatial resolution MRI of breast lesions: qualitative and quantitative comparisons.
    Fan X; Abe H; Medved M; Foxley S; Arkani S; Zamora MA; Olopade OI; Newstead GM; Karczmar GS
    J Magn Reson Imaging; 2006 Dec; 24(6):1311-5. PubMed ID: 17096393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound.
    Vassiou K; Kanavou T; Vlychou M; Poultsidi A; Athanasiou E; Arvanitis DL; Fezoulidis IV
    Eur J Radiol; 2009 Apr; 70(1):69-76. PubMed ID: 18295425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging.
    Hylton NM
    Magn Reson Imaging Clin N Am; 2001 May; 9(2):321-32, vi. PubMed ID: 11493422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidentally detected lesions on contrast-enhanced MR imaging in candidates for breast-conserving therapy: correlation between MR findings and histological diagnosis.
    Yabuuchi H; Kuroiwa T; Kusumoto C; Fukuya T; Ohno S; Hachitanda Y
    J Magn Reson Imaging; 2006 Apr; 23(4):486-92. PubMed ID: 16521096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MR imaging of medullary carcinoma of the breast.
    Tominaga J; Hama H; Kimura N; Takahashi S
    Eur J Radiol; 2009 Jun; 70(3):525-9. PubMed ID: 18353587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast MR imaging: applications and pitfalls.
    Hoisington LA; Scherer DL; Berger KL
    Radiol Technol; 2007; 78(5):367-77. PubMed ID: 17519373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience.
    Orel SG; Rosen M; Mies C; Schnall MD
    Radiology; 2006 Jan; 238(1):54-61. PubMed ID: 16304093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of lesion appearance and histologic findings for the nodes of a breast MR imaging interpretation model.
    Nunes LW; Schnall MD; Orel SG; Hochman MG; Langlotz CP; Reynolds CA; Torosian MH
    Radiographics; 1999; 19(1):79-92. PubMed ID: 9925393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiating benign from malignant enhancing lesions identified at MR imaging of the breast: are time-signal intensity curves an accurate predictor?
    Orel SG
    Radiology; 1999 Apr; 211(1):5-7. PubMed ID: 10189447
    [No Abstract]   [Full Text] [Related]  

  • 32. Value of 3T 1H-magnetic resonance spectroscopy in the differentiation of benign and malignant breast tumors.
    Battal B; Akgun V; Karaman B
    Acta Radiol; 2014 May; 55(4):416-7. PubMed ID: 24757185
    [No Abstract]   [Full Text] [Related]  

  • 33. Breast magnetic resonance imaging: management of an enhancing focus.
    Ha R; Comstock CE
    Radiol Clin North Am; 2014 May; 52(3):585-9. PubMed ID: 24792658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast: visualizing Ca not seen by radiography.
    Harms SE; Flamig DP
    Diagn Imaging (San Franc); 1993; 15 Suppl():20-4. PubMed ID: 10148788
    [No Abstract]   [Full Text] [Related]  

  • 35. Breast MRI for monitoring images of an "adenomyoepithelioma with malignant features", before, during, and after chemotherapy.
    Leung TK; Chu JS; Huang PJ; Lin YH; Lee CM; Chen CS; Tai CJ; Wu CH
    Breast J; 2010; 16(6):652-3. PubMed ID: 21070443
    [No Abstract]   [Full Text] [Related]  

  • 36. Delineating Extramammary Findings at Breast MR Imaging.
    Gao Y; Ibidapo O; Toth HK; Moy L
    Radiographics; 2017; 37(1):10-31. PubMed ID: 28076009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extramammary findings in T2-weighted MR breast images.
    Verslegers I; Van Goethem M; Hufkens G; Biltjes I; Parizel PM
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S181-2. PubMed ID: 23083582
    [No Abstract]   [Full Text] [Related]  

  • 38. Predict, Then Act: Moving Toward Tailored Prevention.
    Kuhl CK
    J Clin Oncol; 2019 Apr; 37(12):943-945. PubMed ID: 30844319
    [No Abstract]   [Full Text] [Related]  

  • 39. Architectural planning for nonprint media.
    Basler TG; Spencer DA
    Bull Med Libr Assoc; 1976 Jan; 64(1):65. PubMed ID: 16017699
    [No Abstract]   [Full Text] [Related]  

  • 40. Application of Imaging Technologies in Breast Cancer Detection: A Review Article.
    Lima ZS; Ebadi MR; Amjad G; Younesi L
    Open Access Maced J Med Sci; 2019 Mar; 7(5):838-848. PubMed ID: 30962849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.